Brain Cancer Therapy Shows Promise in Pediatric Clinical Trial
A new antibody therapy for children with medulloblastoma has shown promise during a Phase I clinical trial. The antibody, which targets a protein that enables cancer cells to multiply and spread, was well tolerated and helped to stabilize the disease, helping to preserve the patients’ quality of life.